The Chennai based medical equipment manufacturer, Trivitron, has signed an agreement with Celerus Diagnostics, USA, to be its exclusive distribution partner in India.

Celerus Diagnostics develops innovative technological solutions that enhance the diagnostic capabilities of anatomic pathology laboratories, provide clinicians with rapid, reliable, actionable diagnostic information, and advance patient care. After many years working with cancer-patient biopsy samples, understanding the needs of testing laboratories and the pathologists who interpret the critical results, the Celerus brought out a Rapid IHC (Immuno Histo Chemistry) solution.

Based on its success, Celerus introduced its second-generation System, the Wave RPD. The Wave RPD System opens the door for improved lab efficiency, Intraoperative applications, and greater physician and patient benefits. The totally automated Wave RPD System is the fastest, most technologically advanced IHC staining platform in the world today. The Wave RPD System improves patient care and reduces health care costs by delivering actionable diagnostic information efficiently.

Trivitron has been working to bring out medical technology products for healthcare service providers in India and emerging markets of the world. It prefers to partner with global medical technology that specializes in single product line and can offer latest technology with good technical support, according to sources in the company.

The Wave RPD is a fully automated Immunohistochemistry system and compatible reagents. This system provides total and rapid automation (128 slides/ hour) for Immunohistochemistry slides, Immunocytochemistry slides, Immunofluorescence slides and In-situ hybridization slide.

The System is US FDA approved and is already cited in many scientific publications.